RESUMEN
AIM: The optimal preparation conditions of Salmon decalcified bone matrix (S-DBM) were explored, and the properties of S-DBM bone particles and bone powder were studied respectively. The therapeutic effect of S-DBM on tibial defect in female Sprague Dawley (SD) rats was preliminarily verified. METHODS: This study assessed the structural and functional similarities of Salmon bone DBM (S-DBM). The biocompatibility assessment was conducted using both in vivo and in vitro experiments, establishing an animal model featuring tibial defects in rats and on the L929 cell line, respectively. The control group, bovine DBM (bDBM), was compared to the S-DBM-treated tibial defect rats. Imaging and histology were used to study implant material changes, defect healing, osteoinductive repair, and degradation. RESULTS: The findings of our study indicate that S-DBM exhibits favorable repairing effects on bone defects, along with desirable physicochemical characteristics, safety, and osteogenic activity. CONCLUSIONS: The S-DBM holds significant potential as a medical biomaterial for treating bone defects, effectively fulfilling the clinical demands for materials used in bone tissue repair engineering.
RESUMEN
Achieving net-zero CO2 emissions is the current main focus of China's carbon neutrality goal. However, non-CO2 greenhouse gases (GHGs) are more powerful climate forcers, making their emission reduction an opportunity to rapidly mitigate future warming. Here, we evaluate non-CO2 mitigation potentials, costs and climate benefits in the context of China's carbon neutrality goals. The assessment is conducted by coupling the integrated assessment model GCAM with a climate emulator. The findings indicate that mitigation technologies can largely reduce fluorinated gas emissions from industrial sectors, but long-term non-CO2 reductions of energy sector activities rely heavily on fuel switching. Furthermore, the cumulative costs of deploying non-CO2 mitigation technologies are projected to be less than 10 % of the total costs of achieving carbon neutrality from 2020 to 2060. If non-CO2 mitigation measures are included in the overall mitigation portfolio, the benefits of avoided warming would by far outweigh the total mitigation cost increase. Our results thus highlight that incorporating a wider suite of GHGs into climate change mitigation strategies can enhance the cost-effectiveness of mitigation efforts.
RESUMEN
Nile tilapia (hereinafter referred to as tilapia) is a species with high economic value and extensive cultivation. In this study, the low-temperature Nile tilapia skin collagen powder (TSCP) was prepared by liquid nitrogen freeze pulverization. After physical and chemical analysis of its properties, it was found that its characteristics were similar to those of type I collagen. The three-dimensional helix structure of protein peptide is good and non denatured. It shows that cryogenic temperature guarantees the activity of TSCP. In addition, TSCP has good biocompatibility. Specifically, it has good blood compatibility, lacks cytotoxicity, will not cause intradermal stimulation and acute systemic toxicity, and has no obvious rejection after implantation. In the rat liver hemorrhage model and wound repair model, compared with the commercially available bovine collagen powder (BSCP), TSCP has better blood coagulation ability: the shortest hemostatic time (135 s) and wound healing efficiency: the wound healing is obvious on the 14th day. The results of this study indicate that the TSCP is an ideal candidate for hemostatic agents and wound healing dressings.
Asunto(s)
Cíclidos , Hemostáticos , Tilapia , Animales , Bovinos , Ratas , Cíclidos/metabolismo , Polvos/análisis , Polvos/metabolismo , Temperatura , Cicatrización de Heridas , Colágeno/análisis , Piel/metabolismo , Tilapia/metabolismo , Hemostáticos/análisis , Hemostáticos/metabolismo , Coagulación Sanguínea , Hemorragia , HemostasisRESUMEN
While stem cell transplantation has emerged as a promising approach to improving wound healing outcomes, the application of stem cells to date has been limited by the poor survival and retention of these cells once transplanted. The survival, development, and migratory activity of transplanted cells can be improved through the use of three-dimensional (3D) culture systems. Here, a novel alginate microsphere-collage hydrogel (AMS-Col gel) 3D culture system was developed and found to improve human umbilical cord mesenchymal stem cell (hUCMSC) survival, permitting their sustained release so as to promote wound healing. Through hematoxylin and eosin staining and Masson's trichrome staining, the prepared hUCMSCs-AMS-Col gel was found to exhibit wound healing activity. On day 7 following the hUCMSCs-AMS-Col gel treatment of model wounds, improved collagen fiber deposition and re-epithelialization were evident, with complete epithelial regeneration as of day 14 and near-total wound healing was evident as of day 21. This hUCMSCs-AMS-Col gel was also associated with increased VEGF and FGF2 expression. Together, these data indicate that AMS-Col gels are a promising and novel form of 3D cell culture system capable of improving hUCMSC-mediated wound healing, highlighting the potential clinical utility of this regenerative strategy.
RESUMEN
Objective: To study the clinical values and implications for the prognosis of procalcitonin (PCT) combined with C-reactive protein (hs-CRP) in patients with bacterial bloodstream infection. Methods: One hundred and twenty patients with infection hospitalized from Mar. 2020 to Jun. 2021 were chosen as subjects. All participants were tested for serum PCT, hs-CRP, and blood culture. According to the types of pathogenic bacteria, they were divided into the gram-negative bacteria bloodstream infection group (n = 53) and the gram-positive bacteria bloodstream infection group (n = 31). Depending on the prognostic outcome of the participants after 28 days, they were categorized into survival and fatality cohorts. The PCT and hs-CRP levels were compared to explore diagnostic value implications for the prognosis of the cases with bacterial bloodstream infection. Results: Serum PCT and hs-CRP values in the positive cohort were higher than those in the negative cohort. The levels of serum PCT and hs-CRP in pulmonary infection were higher than those in the group with negative cases, and the difference was statistically significant (P < 0.05). There were 27 gram-positive participants and 9 gram-negative cases in the positive cohort. The serum PCT value of gram-negative bacterial infection was greater than that of gram-positive bacterial infection. The value of serum PCT in the gram-negative bacterial infection group was higher than that in the gram-positive bacterial infection group, and the difference was statistically significant (P < 0.05). The areas under the curve (AUCs) of PCT, combination of hs-CRP and PCT, and hs-CRP were 0.946, 0.783, and 0.991, respectively. The combined examination of PCT and hs-CRP was the largest, PCT was the second, and hs-CRP was the lowest. These results indicated that the accuracy of combined detection of PCT and hs-CRP in the diagnostic bloodstream infection was the highest (0.991), followed by PCT (0.946) and the lowest (0.783). The PCT and hs-CRP levels of the survival cohort were lower than those in the death cohort. AUCs of PCT, hs-CRP and PCT, and hs-CRP were 0.848, 0.826, and 0.934, respectively. The combined examination of PCT and hs-CRP was the largest, followed by PCT and hs-CRP. The accuracy of the combination of PCT and hs-CRP was the highest (0.934), followed by PCT (0.848), and the diagnostic accuracy of hs-CRP was the lowest (0.826). Conclusion: There were significant differences in the levels of PCT and CRP between the gram-positive bacteria group and the gram-positive bacteria group. PCT and CRP have high diagnostic values in predicting the short-term prognosis of patients. PCT and CRP assist clinical diagnosis and guide treatment and play a positive role in early treatment and prognosis evaluation of patients.
Asunto(s)
Bacteriemia , Infecciones por Bacterias Gramnegativas , Infecciones por Bacterias Grampositivas , Sepsis , Bacteriemia/diagnóstico , Bacterias , Proteína C-Reactiva/metabolismo , Calcitonina , Infecciones por Bacterias Gramnegativas/diagnóstico , Infecciones por Bacterias Grampositivas/diagnóstico , Humanos , Polipéptido alfa Relacionado con Calcitonina , Pronóstico , Sepsis/diagnósticoRESUMEN
Saussurea involucrata is an endangered plant that is used in traditional Chinese medicine. Through the use of plant cell culture techniques, preparations of Saussurea involucrata (S. involucrata) cell cultures have been developed and used to generate medicinal preparations. There have been few evidence-based analyses of the toxicological effects of S. involucrata culture conducted to date. Here, we conducted the experiments designed to assess the acute, subchronic, and genotoxic toxicological effects of S. involucrata culture. The genotoxic study was assessed through Ames, marrow micronucleus, and sperm malformation assays. The acute toxicity was assessed by orally administering in rats and mice at dose of 7500 mg/kg. Subchronic toxicity studies were then conducted by administering rats at doses of 500, 1000, or 1500 mg/kg for 90 days. No genotoxicity was observed at any tested dose levels, nor was any evidence of acute toxicity detected in treated mice or rats. Similarly, subchronic study of S. involucrata culture administration was not associated with any changes in rat food intake, weight, hematological parameters, organ weight, or organ histology. Then, we determined that the no observed adverse effect level of S. involucrata culture was greater than 1500 mg/kg in our 90-day toxicity study.
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Extractos Vegetales/toxicidad , Saussurea/citología , Administración Oral , Animales , Células Cultivadas/química , Daño del ADN/efectos de los fármacos , Femenino , Masculino , Ratones , Pruebas de Mutagenicidad , Nivel sin Efectos Adversos Observados , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Ratas , Saussurea/química , Pruebas de Toxicidad Aguda , Pruebas de Toxicidad SubcrónicaRESUMEN
Despite evidence that breast cancer screening effectively diagnoses and treats cancer through early detection, mammography use remains low in Taiwan. We applied the health belief model (HBM) and the knowledge-attitude-behavior (KAB) model as theoretical frameworks to examine factors associated with mammography uptake among women aged 45-69 years in Taiwan. A cross-sectional survey January-July 2018 was conducted of women aged 45-69 years in five southern Taiwan health institutions. Survey questionnaires included demographics, HBM constructs, and health knowledge regarding breast cancer and screening. Multivariable logistic regression models explored the mediation effects of HBM constructs between health knowledge and mammography use. The final analytical sample included 621 women; 67 did not receive mammography and 554 received mammography. When the regression model was adjusted only for demographic factors, women with adequate health knowledge were more likely to undergo mammography (AOR = 2.321, 95%CI = 1.141-3.809); in regression models including health knowledge and HBM constructs, the likelihood effect of health knowledge declined and became insignificant (AOR = 1.711, 95%CI = 0.985-2.972), indicating potential mediation effects between health knowledge and up-to-date mammography use. Overall, based on the HBM and the KAB theoretical framework, our data support that health belief played a substantial mediating role in the association between health knowledge and mammography uptake, in particular perceived barriers and cues to action in the HBM, which were modifying factors of health beliefs. Therefore, to improve mammography uptake, it may be helpful to design educational model-based interventions through tackling those modifiable perceived barriers and enhancing the intensity of external cues to action.
Asunto(s)
Neoplasias de la Mama , Neoplasias de la Mama/diagnóstico , Estudios Transversales , Detección Precoz del Cáncer , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Mamografía , Tamizaje Masivo , Encuestas y Cuestionarios , TaiwánRESUMEN
As bioenergy produces neutral or even negative carbon emissions, the assessment of biomass resources and associated emissions mitigation is a key step toward a low carbon future. However, relevant comprehensive estimates lack in China. Here, we measure the energy potential of China's domestic biomass resources (including crop residues, forest residues, animal manure, municipal solid waste and sewage sludge) from 2000 to 2016 and draw the spatial-temporal variation trajectories at provincial resolution. Scenario analysis and life cycle assessment are also applied to discuss the greenhouse gas mitigation potentials. Results show that the collectable potential of domestic biomass resources increased from 18.31 EJ in 2000 to 22.67 EJ in 2016 with overall uncertainties fluctuating between (-26.6%, 39.7%) and (-27.6%, 39.5%). Taking energy crops into account, the total potential in 2016 (32.69 EJ) was equivalent to 27.6% of China's energy consumption. If this potential can be realized in a planned way to displace fossil fuels during the period 2020-2050, cumulative greenhouse gas emissions mitigation would be in the range of 1652.73-5859.56 Mt CO2-equivalent, in which the negative greenhouse gas emissions due to the introduction of bioenergy with carbon capture and storage would account for 923.78-1344.13 Mt CO2-equivalent. Contrary to increasing bioenergy potentials in most provinces, there are declining trends in Tibet, Beijing, Shanghai and Zhejiang. In addition, Yunnan, Sichuan and Inner Mongolia would have the highest associated greenhouse gas mitigation potentials. This study can provide valuable guidance on the exploitation of China's untapped biomass resources for the mitigation of global climate change.